$DVAX
Market Cap:
$DVAX SEC Filings
| Filing | Filed On |
|---|---|
| 4 | 24 Oct 2008 |
| FDA RESPONSE | 22 Oct 2008 |
| SC 13G | 17 Oct 2008 |
| MANAGEMENT CONTINUITY | 08 Oct 2008 |
| OCTOBER GRANT | 07 Oct 2008 |
| OCTOBER GRANT | 07 Oct 2008 |
| OCTOBER GRANT | 07 Oct 2008 |
| OCTOBER GRANT | 07 Oct 2008 |
| OCTOBER GRANT | 07 Oct 2008 |
| NIH NIAID CONTRACT | 29 Sep 2008 |
| ASTRAZENECA MILESTONE | 24 Sep 2008 |
| FDA RESPONSE SUBMISSION | 18 Sep 2008 |
| SC 13G/A | 10 Sep 2008 |
| FORM 8-K | 28 Aug 2008 |
| REGISTRATION STATEMENT ON FORM S-8 | 06 Aug 2008 |
| FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2008 | 06 Aug 2008 |
| 2Q 2008 FINANCIAL RESULTS & PHASE 3 HEPLISAV DATA | 06 Aug 2008 |
| 4 | 30 Jun 2008 |
| 2008 ANNUAL STOCK OPTION GRANT | 13 Jun 2008 |
| 2008 ANNUAL STOCK OPTION GRANT | 13 Jun 2008 |
